VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
VEON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
VEONVEON Ltd.
$76.85$5.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksVEONBalance Sheet

VEON Ltd. (VEON) Balance Sheet

19Y historyFree accessUpdated daily

Total debt of $5.6B against equity of $1.7B (debt-to-equity of 2.74, down from 3.86 in 2024Q2) indicates elevated leverage that may amplify sensitivity to rupee depreciation or refinancing pressure, with only 20% of assets equity-financed.

Income StatementBalance SheetCash FlowRatios

VEON Balance Sheet

Annual statement

VEON Balance Sheet

VEON Ltd. (VEON) balance sheet — 19-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Total Assets10.28B9.21B8.04B8.22B15.08B15.92B14.55B16.06B14.1B19.52B21.28B33.84B41B50.42B55.36B54.48B19.93B14.73B15.73B10.57B
Asset Growth %69.13%14.65%-2.21%-45.51%-5.26%9.42%-9.39%13.88%-27.76%-8.26%-37.12%-17.45%-18.69%-8.93%1.62%173.37%35.26%-6.31%48.79%-
PP&E (Net)4.09B3.76B3.02B2.9B2.85B6.72B6.88B7.34B4.93B6.1B6.72B6.24B11.85B15.56B15.67B14.87B6.9B5.56B6.43B5.5B
PP&E / Total Assets %39.74%40.77%37.53%35.26%18.88%42.19%47.28%45.71%34.97%31.23%31.58%18.44%28.9%30.87%28.3%27.3%34.62%37.75%40.86%52.02%
Total Current Assets3.56B3.11B2.9B3.16B3.98B5.42B2.85B2.5B3.11B3.94B4.55B20.52B9.59B8.76B9.54B7.18B2.33B2.97B2.41B1.73B
Cash & Equivalents2.03B1.73B1.69B1.9B3.11B2.25B1.67B1.25B1.81B1.3B2.94B3.61B6.34B4.45B4.95B2.33B885.13M1.45B914.68M1B
Receivables1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Inventory42M31.99M15M23M73M111M111M169M141M72M125M104M117M192M167M589M137.41M61.92M142.65M58.84M
Other Current Assets231M704.88M218M60M54M2.02B133M151M196M238M32M15.33B455M427M134M-348M475.94M703.05M172.81M138.84M
Long-Term Investments430.97M143.97M65M53M71M99M305M235M58M1.96B2.57B365M867M711M2.26B1.27B446.13M436.77M493.55M5.91M
Goodwill00338M349M394M1.54B2.68B3.96B3.82B4.39B4.7B4.22B10.29B14.71B16.96B17.03B7B3.28B3.48B1.04B
Intangible Assets01.55B1.17B1.27B1.57B1.7B1.47B1.73B1.85B2.17B2.26B2.22B7.72B9.84B10.6B11.77B2.67B1.69B2.2B1.8B
Other Assets239M233.96M177M178M5.95B216M179M163M135M227M143M133M117M70M18M1.02B581.23M790.99M220.84M388.58M
Total Liabilities8.23B7.58B6.78B7.15B14.32B14.42B13.54B13.84B11.32B15.59B15.15B29.98B37.06B39.11B39.99B39.03B9.12B9.72B11.12B4.87B
Total Debt5.61B5.14B4.69B5.16B8.18B10.65B10.06B10.34B7.86B11.63B11.12B9.79B27.12B26.8B25.69B28.84B5.66B7.35B8.44B2.77B
Net Debt3.58B3.41B3B3.25B5.07B8.39B8.42B9.09B4.76B10.32B8.17B6.17B20.78B22.35B20.74B26.52B4.78B5.91B7.53B1.76B
Long-Term Debt4.37B4.04B3.03B3.46B5.34B9.4B8.83B7.76B6.56B10.36B8.07B8.09B23.94B26.8B25.69B25.41B4.96B5.54B6.29B2.24B
Short-Term Borrowings1.24B1.1B1.67B1.69B2.84B1.24B1.25B2.58B1.29B1.27B3.05B1.69B3.19B2.43B3.39B3.12B1.23B1.81B1.91B526.51M
Capital Lease Obligations000000000000000311M176M316K241.47M0
Total Current Liabilities3.74B3.43B3.63B3.58B4.64B4.38B4.41B5.77B4.41B4.64B6.56B5.54B10.56B11.31B11.88B10.29B3.17B3.41B3.81B2B
Accounts Payable1.74B1.44B1.28B1.2B1.09B2.03B1.95B1.85B1.43B1.54B1.74B1.77B4.01B4.73B4.58B4.57B1.02B545.69M896.09M697.82M
Accrued Expenses0080M84M82M153M168M197M197.93M173M135.99M167.97M224M223M261M263M108M113.37M105.79M175.2M
Deferred Revenue00129M144M159M212M216M225M350.88M374M552.94M145.98M203M89M89M80M47M28.71M29.47M423.61M
Other Current Liabilities664.01M799.86M296M310M293M517M650M811.99M1.11B1.23B1.02B1.74B2.87B3.67B3.36B1.87B713M699.99M750.97M92.03M
Deferred Taxes193.99M1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Liabilities64M64.99M90M60M4.29B494M152M153M156.95M209M177.98M15.9B811M676M778M1.3B151M128.87M93.35M15.85M
Total Equity2.05B1.63B1.26B1.07B767M1.5B1.01B2.22B2.78B3.93B6.04B3.89B3.98B9.08B15.37B15.45B10.81B5.02B4.61B5.7B
Equity Growth %117.02%29.97%17.37%39.63%-49.04%48.57%-54.37%-20.12%-29.23%-35.02%55.19%-2.06%-56.2%-40.94%-0.48%42.86%115.51%8.84%-19.13%-
Shareholders Equity1.65B1.34B1.1B858M569M586M163M1.23B3.67B4.35B5.96B3.77B5.01B9.73B14.87B14.04B10.67B4.51B4.39B5.41B
Minority Interest398M293.95M158M213M198M919M850M994M-891M-425M82M129M-1.03B-655M503M1.4B142.06M510.63M221.04M288.41M
Common Stock2M2M2M2M2M2M2M2M2M2M2M2M2M2M2M2M1.3M1.03M92K92K
Additional Paid-in Capital12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.75B12.93B11.54B11.54B6.29B1.14B1.17B1.41B
Retained Earnings-2.59B-3B-3.53B-3.94B-1.41B-1.25B-1.92B-1.33B-1.41B-1.49B-439M-2.71B-1.99B-1.29B4.76B3.91B5.15B4.07B3.27B3.33B
Accumulated OCI-8.51B-8.42B-8.13B-7.96B-10.78B-10.92B-10.67B-10.2B-7.67B-6.94B-6.36B-6.28B-5.75B-1.72B-1.22B-1.21B-561.15M-488.28M-88.94M801.24M
Return on Assets (ROA)3.84%6.27%5.11%-21.7%-1.04%4.42%-2.28%4.12%3.46%-2.48%8.45%-1.75%-1.42%-3.77%2.8%1.46%10.42%7.37%3.99%13.84%
Return on Equity (ROE)20.26%37.44%35.65%-275.08%-14.26%53.53%-21.59%24.89%17.36%-10.13%46.86%-16.65%-9.91%-16.29%9.99%4.14%22.82%23.31%10.17%25.66%
Debt / Equity2.74x3.15x3.73x4.81x10.66x7.07x9.93x4.66x2.83x2.96x1.84x2.51x6.82x2.95x1.67x1.87x0.52x1.47x1.83x0.49x
Debt / Assets54.57%55.83%58.41%62.74%54.23%66.87%69.11%64.41%55.71%59.58%52.24%28.92%66.16%53.16%46.41%52.94%28.41%49.91%53.69%26.18%
Net Debt / EBITDA1.64x1.84x1.63x1.96x2.58x4.61x5.21x2.38x1.99x2.90x2.68x2.38x4.60x4.17x2.12x3.47x0.99x1.38x1.70x0.49x
Book Value per Share29.1722.7717.3515.0310.8921.3714.4831.7339.7256.1386.3855.6656.85129.82237.37253.39223.96123.75113.54140.4

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetStrained
Cash FlowImproving
Top Statement Risk

Leverage amplifies FX exposure

Asset Base Expanding Faster Than Equity

Based on EDBL's reported figures, total assets rose from $7.3B in 2024Q2 to $10.3B in 2026Q3, a 41% increase, while equity grew from $911.0M to $1.7B, suggesting asset growth is being funded disproportionately by liabilities rather than retained earnings.

PPE net expanded from $2.9B to $4.1B over the same ten quarters, consistent with sustained network build-out in frontier markets. Equity/Assets improved only from 0.15 to 0.20, which suggests the asset growth has been largely debt-financed and that regulated-style equity accretion is lagging the capital deployed. Investors should monitor whether future earnings retention closes this gap or whether further leverage is required.

Elevated Leverage Persists Despite Deleveraging Signs

As reported in financial statements, VEON's debt-to-equity ratio moved from 3.86 in 2024Q2 to 2.74 in 2026Q3, a meaningful improvement, yet total debt of $5.6B still exceeds equity by more than three times.

The downward trend in D/E is encouraging, but the absolute debt load remains high relative to a thin equity base, which may limit flexibility if FX or macro shocks reduce USD-reported earnings. Because the reported figures do not disclose authorized versus actual capital structure parameters, a true regulatory-style leverage headroom assessment cannot be made, and this warrants further investigation.

Working Capital Ratio Hovers Near Parity

Per the reported quarterly data, the current ratio ranged from 0.78 to 0.97 across the ten quarters, with the most recent reading at 0.95, indicating current liabilities have consistently approximated or exceeded current assets.

A current ratio persistently below 1.0 suggests short-term obligations are closely matched to liquid resources rather than comfortably covered. Cash of $2.5B in 2026Q3 provides a meaningful buffer, but its adequacy depends on the maturity profile of the debt stack, which the supplied data does not disclose. Investors should monitor short-term debt rates and refinancing timing.

Equity Recovery Volatile and Thin

Based on VEON's reported figures, ROE swung from 41.3% in 2025Q2 to -8.3% in 2025Q3 and settled at 9.5% in 2026Q3, a pattern that reflects earnings volatility on a small and fragile equity base.

The erratic return profile suggests that reported ROE is driven more by non-recurring items and FX translation than by steady operating retention. With equity at only $1.7B against $10.3B in assets, small earnings swings translate into large percentage ROE moves. No dividend data is supplied, so payout safety is treated as data unavailable.

Leverage Magnifies Currency and Earnings Shocks

As reported in the financial statements, VEON's equity-to-assets ratio of 0.20 means roughly 80% of the asset base is financed by liabilities, which may amplify sensitivity to any Pakistan rupee depreciation or refinancing pressure.

Because a large share of reported assets are financed by debt, a currency-driven fall in USD-reported asset values could compress equity disproportionately. This analysis is inference from reported ratios rather than confirmed exposure, and the supplied data does not isolate the currency composition of the debt. Investors should investigate the currency mix and maturity profile of borrowings before assuming the leverage is adequately hedged.

VEON — Frequently Asked Questions

Quick answers to the most common questions about buying VEON stock.

What are the total assets of VEON Ltd. (VEON)?

As of 2025, VEON Ltd. (VEON) had total assets of $9.21B including $3.11B in current assets.

How much debt does VEON Ltd. (VEON) have?

VEON Ltd. (VEON) carries total debt of $5.14B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of VEON Ltd.?

VEON Ltd. (VEON) has total shareholders' equity (book value) of $1.34B ($22.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is VEON Ltd.'s current ratio and liquidity?

VEON Ltd. (VEON) reported a current ratio of 0.91x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.